Efficacy and Safety of the Novel Selective Nicotinic Acetylcholine Receptor Partial Agonist, Varenicline, for Smoking Cessation
Archives of Internal Medicine
doi 10.1001/archinte.166.15.1571
Full Text
Open PDFAbstract
Available in full text
Date
August 14, 2006
Authors
Publisher
American Medical Association (AMA)